Journal
CANCERS
Volume 13, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/cancers13040749
Keywords
extracellular vesicles; cancer drug resistance; chemotherapy; MDR transporters; miRNAs; tumor microenvironment; cancer stem cells
Categories
Funding
- BBSRC [BB/P006205/1]
- Cancer Research UK [A28052]
- AIRC fellowship for Italy
- BBSRC [BB/P006205/1] Funding Source: UKRI
Ask authors/readers for more resources
Extracellular vesicles play a crucial role in the development of cancer drug resistance, affecting tumor cells' sensitivity to treatment through various mechanisms. They have the potential to serve as diagnostic and therapeutic targets in cancer therapy.
Simple Summary Drug resistance still represents the main reason for therapy failure in cancer patients. In the last decade, extracellular vesicles (EVs), a heterogeneous group of particles implicated in cell-to-cell communication, have been shown to substantially contribute to this phenomenon. This review summarizes the molecular mechanisms underlying the EV-mediated development of chemoresistance, shedding light on the potential role of these vesicles as both diagnostic/prognostic markers and therapeutic targets. Extracellular vesicles (EVs) have recently emerged as crucial modulators of cancer drug resistance. Indeed, it has been shown that they can directly sequester anti-tumor drugs, decreasing their effective concentration at target sites. Moreover, they facilitate the horizontal transfer of specific bioactive cargoes able to regulate proliferative, apoptotic, and stemness programs in recipient cells, potentially conferring a resistant phenotype to drug-sensitive cancer cells. Finally, EVs can mediate the communication between the tumor and both stromal and immune cells within the microenvironment, promoting treatment escape. In this context, clarifying the EV-driven resistance mechanisms might improve not only tumor diagnosis and prognosis but also therapeutic outcomes. Detailed cellular and molecular events occurring during the development of EV-mediated cancer drug resistance are described in this review article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available